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INTRODUCTION 33 
Within the last decade there has been a dramatic increase in the sale and use of CAM especially herbal 34 
dietary supplements by individuals within the UK. Sales of herbal dietary supplements by individuals 35 
within the UK have been increasing (1). Use of CAM by the UK population can be attributed to several 36 
factors, including personal belief, increased media publicity and changes in public attitude (1, 2). 37 
However, there is a considerable debate around the definition of CAM and definitions varying over time 38 
(3). CAM can be defined as “any health improving technique outside of the mainstream of conventional 39 
medicine (3).  40 
 41 
People, who use CAM, do so because they hold beliefs about health, treatment and illness which are 42 
congruent with CAM, have chronic health problems, and are disillusioned with the experience and 43 
outcomes from conventional medicine (4). Currently substantial numbers of people are turning to CAM. It 44 
is very popular, with recent population based estimates of yearly adult use in the UK of 20% to 28% (3). 45 
The prevalence of the CAM use in the general population in the USA increased from 34% in 1990 to 39% 46 
in 1997 (5) and remained stable from 1997 to 2002. In the UK, 46% of the population can be expected to 47 
use one or more CAM therapies in their life time (6). There is a remarkable interest in CAM remedies by 48 
diabetic patients for active engagement in health and disease self-management (3). The objective of this 49 
study is to determine whether individuals with self-reported FeMS were more likely to use different CAM 50 
therapies compared with individuals without FeMS. Furthermore, FeMS was defined as any individuals 51 
having at least one clinically diagnosed self-reported health condition of diabetes or hypertension or 52 
hyper-cholesterol or obesity. 53 
 54 
MATERIALS AND METHODS 55 
The study protocol was approved by the Faculty research ethics committee, University of West London 56 
(FREC31/Feb07). The participants in this study were 25 years or older and employed by University of 57 
West London, UK. A total of 300 individuals were randomly invited to participate in this study. 58 
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Participants were asked to complete a self-administered questionnaire on their socio demographic 59 
characteristics, lifestyle characteristics, perceived health status, and regular CAM use in the past 12 60 
months.  61 
 62 
Metabolic syndrome is a metabolic abnormality associated with dyslipidemia, hypertension, abdominal 63 
obesity, and Impaired Glucose Tolerance (IGT). The diagnosis of FeMS was defined as any individuals 64 
having at least one clinically diagnosed self-reported health condition of diabetes or hypertension or 65 
hyper-cholesterol or obesity. FeMS has been reported and defined in previous studies (7). Cross 66 
tabulation/Chi square statistics were used to   compare individuals with FeMS to those without FeMS . All 67 
statistical analysis was performed using SPSS (version 15). 68 
 69 
RESULTS 70 
Of the 300 questionnaires administered, 192 individuals completed and returned the questionnaires (64% 71 
response rate). The majority (83%; n=159) were under 54 years and 65% were females (Table 1).  Self-72 
reported FeMS were; diabetes (n=10), hypertension (n=11), hyper cholesterolaemia (n=19) and obesity 73 
(n=39). Just over a quarter of individuals had at least one self-reported FeMS.  74 
 75 
Among individuals with FeMS (n=54), approximately 68% (n=37) had only one self-reported health 76 
condition of either diabetes or hypertension or hyper cholesterol or obesity, while 24% (n=13) and 7% 77 
(n=4) had two and three or four self-reported conditions respectively. Over a third were currently using or 78 
had used CAM in the past 12 months (Table-1). The five most common CAM remedies used were 79 
nutritional supplements (87%; n=66), massage therapy (42%, n=32), acupuncture (26%, n=26), yoga 80 
(26%, n=20) aromatherapy (21%, n=16) and herbal supplements (21%, n=16) (Table-1). The average 81 
expenditure on CAM therapy per month was found to be £37.20 with a range of £5.00 to £75.00 per 82 
month. Table-1 shows that individuals with FeMS were more likely to use different CAM therapies, 83 
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such as nutritional and herbal supplements, aromatherapy and massage therapy (P<0.05) than those 84 
without FeMS. Furthermore, individuals with FeMS were significantly less likely to report or discuss the 85 
use of different CAM therapies with their General Practitioner (Table 1). Individuals with FeMS tended to 86 
be older; young individuals were less likely to have FeMS compared with older individuals (P<0.01) (data 87 
not shown). Individuals with higher education levels of university or postgraduate degrees were more 88 
likely to have FeMS compared with individuals with secondary school education (P=0.027) (data not 89 
shown). Gender, ethnicity and income status of the individuals did not show any significant associations 90 
with FeMS. 91 
Table 1 – The relationship between intake of different CAM therapies and features of MS  92 
 93 
CONCLUSION  94 
There is considerable debate around the definition of CAM and what approaches it includes, such as home 95 
remedies, dietary and herbal supplements (3). Surveys conducted in various developed countries have 96 
shown that personnel use of dietary and herbal supplements is becoming widespread and increasingly 97 
popular (8, 9, 12). This was particularly true for the individuals with FeMS participating in this study 98 
(Table-1). One possible explanation for this is that individuals with FeMS may have had less success in 99 
treating their own health problems and their continued problems may have prompted them to seek CAM 100 
therapies. Other studies have also revealed that patients suffering from chronic diseases have a higher use 101 
of alternative therapies than those who do not have any chronic diseases (10). A recent survey conducted 102 
in Switzerland demonstrated that patients with type-1 diabetes were more likely to use CAM especially, 103 
herbal supplements to improve general wellbeing and ameliorate glucose homeostasis (11).   104 
 105 
One of the important findings in this study was that individuals with FeMS were less likely to report the 106 
use of CAM to their General practitioners which could be due to; being worried about their doctors’ 107 
response.  People may be scared to report the use of various CAM therapies, as doctors may ask them to 108 
stop using CAM therapies because of their potentially adverse effects or interactions with regular 109 
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medications. However, interaction between CAM use and prescription medicine is possible and there are 110 
many reports in the literature of interactions, adverse effects and even fatalities associated with CAM use 111 
(13). Furthermore, Canter & Ernst (12) suggested that the concomitant use of several herbal supplements 112 
is poorly reported to doctors and may place older people at risk of negative herb-drug interaction. 113 
Therefore this issue needs to be addressed by educating the general public or patients to encourage 114 
discussion on the use of different CAM with their doctors (14). Therefore it would be more appropriate 115 
that health care providers and doctors acknowledge the use of CAM, and learn to discuss CAM use with 116 
their patients. There are some potential limitations to this study. Despite a good response rate of 64%, the 117 
small sample, purposive sampling of a university staff is a   limitation and data cannot be generalised to 118 
the population. Recall of the use of CAM therapies in the past 12 months could cause potential bias as 119 
well as possible inaccuracies in the self-reporting or perceived of  medical conditions (diabetes, 120 
hypertension, hyper-cholesterol and obesity), though  previous studies have shown that self-reports are 121 
reliable tools (15).  122 
 123 
In summary, individuals with FeMS were more likely to use different CAM therapies, especially 124 
nutritional and herbal supplements, aromatherapy and massage therapy than individuals without FeMS. 125 
This study provides preliminary data which points to the need for future studies  on the use  and safety of  126 
different CAM practices in people with FeMS. Healthcare professional should be conscious of the 127 
increasing number of patients using CAM remedies, and the use of CAM should be explored with patients 128 
before any clinical judgments made.   129 
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Table 1 – The use of different CAM therapies by individuals with and without FeMS.   200 
CAM Therapies 
Respondents with 
Features of MS (n=54) 
 Respondent without 
Features of MS (n=138) p 
n % n % 
Acupuncture 4 7.4 22 15.9 0.089 
Shiatsu 3 5.6 3 2.2 0.219 
Chiropractic 5 9.3 5 3.6 0.114 
Massage therapy 18 33.3 14 10.1 0.001* 
Reflexology 4 7.4 11 8.0 0.581 
Aromatherapy 8 14.8 8 5.8 0.045* 
Meditation training 3 5.6 4 2.9 0.309 
Yoga 8 14.8 12 8.7 0.162 
Herbal supplements 9 17.0 7 5.0 0.017* 
Dietary/nutritional supplements 34 63.0 32 23.1 0.001* 
Naturopathy 1 1.9 1 0.7 0.484 
Ayurveda medicine 1 1.9 2 1.4 0.631 
Osteopathy 2 3.7 10 7.2 0.292 
Homeopathy 3 5.6 6 4.3 0.488 
Hypnosis 0 0.0 1 0.7 0.719 
Traditional Chinese medicine 2 3.7 5 3.6 0.634 
Use of CAM (n=192)      
currently or in the past 12 months 30 55.5 46 33.3 0.003μ 
Discuss the use of CAM with GP (n=61) β      
Discussed with General Practitioner  4 16.0 18 50.0 0.006a 
Use of one or more CAM therapies (n=76)      
Have used only CAM therapy 5 9.3 11 8.0  
Have used two CAM Therapies 11 20.4 16 11.6  
Have used three or more CAM therapies 14 25.9 19 13.8 0.033‡ 
      
 201 
Data presented as n (%); MS – metabolic syndrome, * P<0.05 shows that individuals with features of MS were more likely to use 202 
dietary or nutritional supplements (P=0.001), herbal supplements (P=0.017), massage therapy (P=0.001) and aromatherapy 203 
(P=0.045) than their counterparts without features of MS.  μ P=0.003 shows that individuals with features of MS are more likely to 204 
use CAM therapies currently or in the past 12 months compared to persons without features of MS. a  P=0.006 shows that 205 
individuals with features of MS were significantly less likely to report or discuss the use of CAM therapies with their General 206 
Practitioner or doctor. ‡ P=0.033 shows that individuals with features of MS were more likely to use 3 or more types of CAM than 207 
individuals without features of MS. β respondents with and without features of metabolic syndrome n=25 and n=36 respectively. 208 
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